Tuesday, July 21

Browsing: ASCERTAINV

Support

ASCERTAIN-V Data Support Oral HMA Combination as AML Frontline Option

By NewsCancerJuly 20, 20260

Data from the phase 1/2 ASCERTAIN-V trial (NCT04657081), which supported the May 2026 FDA approval of oral decitabine/cedazuridine (DEC-C; Inqovi)…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.